BillionToOne

BillionToOne is a precision diagnostics company that focuses on improving disease detection through innovative molecular diagnostics. The company specializes in single molecule diagnostics, utilizing their proprietary technology to quantify biological molecules for enhanced disease detection. Their core offerings include non-invasive prenatal testing and liquid biopsy solutions, which aim to provide accurate and timely insights into patient health from minimal sample sizes, such as a single blood draw.

The primary product for prenatal testing is Unity Complete®, a non-invasive prenatal test (…